Prosecution Insights
Prosecution Insights
5 pending office actions • 3 art units • 3 examiners • 0 of 5 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (20%) |
| No statute on record | 4 (80%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HIBBERT, CATHERINE S | 3 | 59.2% | +48.3% |
| MATALKAH, FATIMAH KHALAF | 1 | 56.3% | +11.5% |
| MEYERING, SHABANA SHABBEER | 1 | 71.2% | +37.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17792203 | CELLS HAVING HIGH ADAPTABILITY UNDER HYPOXIC CONDITIONS, AND USE THEREOF | MATALKAH, FATIMAH KHALAF | 140d overdue |
| 17004355 | COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF | HIBBERT, CATHERINE S | 73d overdue |
| 18313946 | COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF | HIBBERT, CATHERINE S | 31d overdue |
| 17262342 | GENE EDITING OF ANTICOAGULANTS | MEYERING, SHABANA SHABBEER | 23d overdue |
| 18467967 | Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells | HIBBERT, CATHERINE S | 9d overdue |
| Art Unit | Apps |
|---|---|
| 1658 | 3 |
| 1638 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18467967 | Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells | HIBBERT, CATHERINE S | 1658 | Other | Non-Final OA | 9d overdue | Pending | Sep 15, 2023 |
| 18313946 | COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF | HIBBERT, CATHERINE S | 1658 | Other | Non-Final OA | 31d overdue | Pending | May 08, 2023 |
| 17792203 | CELLS HAVING HIGH ADAPTABILITY UNDER HYPOXIC CONDITIONS, AND USE THEREOF | MATALKAH, FATIMAH KHALAF | 1638 | Other | Non-Final OA | 140d overdue | Pending | Jul 12, 2022 |
| 17262342 | GENE EDITING OF ANTICOAGULANTS | MEYERING, SHABANA SHABBEER | 1635 | §103 | Final Rejection | 23d overdue | Pending | Jan 22, 2021 |
| 17004355 | COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF | HIBBERT, CATHERINE S | 1658 | Other | Final Rejection | 73d overdue | Pending | Aug 27, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial